Nearly four decades of study has propelled advances in heart disease, hepatitis, cancer, and other diseases

Trial offers hope for new revaccination strategies with Bacille Calmette-Guerin (BCG) against Tuberculosis, the world's leading infectious disease killer

Drug extends survival, reverses some neuromuscular damage in animals

The pharmaceutical industry is facing unprecedented challenges as the cost of developing new drugs reaches unsustainable levels

Brian Nahed, MD, talks to contributing editor Tanuja Koppal, PhD, about the need to develop techniques to detect and monitor disease progression

To date, gene expression in tumors has been typically profiled by capturing messenger RNAs; however, they represent only a fraction of the molecules detected

Researchers have found that two genes switch off the fetal hemoglobin gene by binding directly to it

Laboratory network standardizes on common NGS platform to efficiently profile patient samples across multiple cancer centers

UCLA-led study will help scientists better understand debilitating condition

Access to world-class LIMS and analytics